Xiangyu Medical Crowned as a Dual Leader in the 2026 China Medical Device R&D Strength Rankings

(Source:Sunnyou Medical）

2026 MDI-China Medical Device Innovation & Collaboration Conference

On May 8, 2026, hosted by Yaozhi Network, and organized by Yaozhi Medical Device Data and Yaozhi Media, with media support from Arterial Network and E-Pharma Managers.2026 MDI-China Medical Device Innovation & Cooperation ConferenceSolemnly convened at the Wuxi International Convention Center, the conference simultaneously released the "2026 Medical Device R&D Strength Rankings." Sunnyou Medical, with its solid R&D capabilities and strategic layout in cutting-edge technologies such as brain-computer interfaces, received two significant honors, once again gaining authoritative recognition within the industry.

Showcase the Strength of the Rehabilitation Equipment Leader

This list, released by Yaozhi.com based on its pharmaceutical big data advantages, provides a scientific evaluation of R&D investment, patent layout, product transformation, technological innovation, and more. It serves as an important indicator of R&D strength in China's medical device industry. Sunnyou Medical delivered an impressive performance this time, earning dual recognition:

2026 Comprehensive Ranking of Medical Device R&D Strength in China, Ranked 5th Nationwide`, second only to`Mindray、United Imaging Healthcare、Lepu Medical、Dabo Medical, is the only company in the rehabilitation equipment sector to rank among the TOP5.

2026 Comprehensive Ranking of Medical Device R&D Strength

2026 Medical Device R&D Strength Ranking: 3rd Place in ChinaSecond only to Mindray Medical and United Imaging Healthcare, the two leading companies in the industry, Sunnyou has achieved significant breakthroughs in the field of high-end medical equipment produced in China.

2026 Medical Device R&D Power Ranking

This achievement is the industry's recognition of Sunnyou's long-term dedication to the rehabilitation equipment field and its commitment to innovation-driven development. It also directly reflects the company's technical strength and industry status. As a leading enterprise in China's rehabilitation medical device sector, Sunnyou Medical Co., Ltd. always focuses on clinical needs and continuously increases investment in research and development.R&D investment reached 189 million yuan in 2025, accounting for 24.65% of revenue., with the industry's first National Enterprise Technology Center/National Industrial Design Center, began to lay out the brain-computer interface direction in 2015 and established brain science/rehabilitation.RobotIn the laboratory, Xiangyu Medical took the lead in establishing a brain-computer interface rehabilitation technology innovation consortium, signed a joint R&D cooperation agreement on minimally invasive brain-computer interface technology with Niels Birbaumer, an academician of the German National Academy of Sciences (professor at the University of Tübingen, Germany), and spearheaded the establishment of the Henan Brain-Computer Interface Rehabilitation Equipment Technology Innovation Center… In recent years, the company’s forward-looking layout has gradually entered the harvest phase, consistently striving to promote the implementation of cutting-edge technological achievements, aiding high-quality development of rehabilitation equipment produced in China. This aligns with the policy direction of upgrading China's medical device "one code access" regulation and expanding the supply of rehabilitation services!

Deep Cultivation, Jointly Opening a New Chapter of "Brain-Computer Interface + Rehabilitation Industry"

This time, the top rankings on both lists are an honor and, more importantly, a motivation. In the future, Sunnyou will continue to uphold the concept of "Technology Empowering Rehabilitation, Innovation Leading the Future," continuously increase R&D investment, deepen the layout of the three major future sectors: brain-computer interface, rehabilitation robots, and AI healthcare, promote the deep integration of technological innovation and clinical needs, align with China's "15th Five-Year Plan" policy direction for expanding rehabilitation and nursing supply and implementing full-lifecycle refined regulation of medical devices, provide patients with higher quality rehabilitation services, contribute to the high-quality development of China’s rehabilitation medical device industry, and create long-term stable value returns for all shareholders.

Editor | Gao Xiaoxue

Proofread by Yang Guang

Review | Shi Xiaoxia